Terms: = Prostate cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Staging
77 results:
1. Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapy.
Ozawa Y; Nohara S; Nakamura K; Hattori S; Yagi Y; Nishiyama T; Yorozu A; Monma T; Saito S
Prostate; 2024 Apr; 84(5):502-510. PubMed ID: 38173289
[TBL] [Abstract] [Full Text] [Related]
2. Defining aggressive prostate cancer: a geospatial perspective.
Wiese D; DuBois TD; Sorice KA; Fang CY; Ragin C; Daly MB; Reese AC; Henry KA; Lynch SM
BMC Cancer; 2023 Aug; 23(1):754. PubMed ID: 37580675
[TBL] [Abstract] [Full Text] [Related]
3. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of selective bone scan staging in prostate cancer - external validation of current strategies and decision-curve analysis.
Hiwase MD; Jay A; Bulamu N; Teh J; Paterson F; Kichenadasse G; Vincent AD; O'Callaghan M;
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):336-343. PubMed ID: 35288662
[TBL] [Abstract] [Full Text] [Related]
5. Sociodemographic and Geographic Disparities of prostate cancer Treatment Delay in Tennessee: A Population-Based Study.
Montiel Ishino FA; Odame EA; Villalobos K; Rowan C; Whiteside M; Mamudu H; Williams F
Am J Mens Health; 2021; 15(6):15579883211057990. PubMed ID: 34836465
[TBL] [Abstract] [Full Text] [Related]
6. Risk of adverse pathological features for intermediate risk prostate cancer: Clinical implications for definitive radiation therapy.
Zhang H; Doucette C; Yang H; Bandyopadhyay S; Grossman CE; Messing EM; Chen Y
PLoS One; 2021; 16(7):e0253936. PubMed ID: 34264975
[TBL] [Abstract] [Full Text] [Related]
7. Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea.
Shin DW; Park J; Yeob KE; Yoon SJ; Jang SN; Kim SY; Park JH; Park JH; Kawachi I
Disabil Health J; 2021 Oct; 14(4):101125. PubMed ID: 34148851
[TBL] [Abstract] [Full Text] [Related]
8. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Clarke NW; Ali A; Ingleby FC; Hoyle A; Amos CL; Attard G; Brawley CD; Calvert J; Chowdhury S; Cook A; Cross W; Dearnaley DP; Douis H; Gilbert D; Gillessen S; Jones RJ; Langley RE; MacNair A; Malik Z; Mason MD; Matheson D; Millman R; Parker CC; Ritchie AWS; Rush H; Russell JM; Brown J; Beesley S; Birtle A; Capaldi L; Gale J; Gibbs S; Lydon A; Nikapota A; Omlin A; O'Sullivan JM; Parikh O; Protheroe A; Rudman S; Srihari NN; Simms M; Tanguay JS; Tolan S; Wagstaff J; Wallace J; Wylie J; Zarkar A; Sydes MR; Parmar MKB; James ND
Ann Oncol; 2019 Dec; 30(12):1992-2003. PubMed ID: 31560068
[TBL] [Abstract] [Full Text] [Related]
9. Metastatic dissemination patterns of different primary tumors to the spine and other bones.
Onken JS; Fekonja LS; Wehowsky R; Hubertus V; Vajkoczy P
Clin Exp Metastasis; 2019 Dec; 36(6):493-498. PubMed ID: 31420767
[TBL] [Abstract] [Full Text] [Related]
10. The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.
Takamatsu K; Matsumoto K; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Shinojima T; Kikuchi E; Asanuma H; Oya M
Urol Oncol; 2019 Sep; 37(9):575.e19-575.e25. PubMed ID: 30967332
[TBL] [Abstract] [Full Text] [Related]
11. Long-term survival of patients with prostate cancer in Martinique: Results of a population-based study.
Joachim C; Ulric-Gervaise S; Dramé M; Macni J; Escarmant P; Véronique-Baudin J; Vinh-Hung V
Cancer Epidemiol; 2019 Apr; 59():193-198. PubMed ID: 30825842
[TBL] [Abstract] [Full Text] [Related]
12. Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer.
Drangsholt S; Walter D; Ciprut S; Lepor A; Sedlander E; Curnyn C; Loeb S; Malloy P; Winn AN; Makarov DV
Urol Oncol; 2019 Feb; 37(2):145-149. PubMed ID: 30578160
[TBL] [Abstract] [Full Text] [Related]
13. Updates on Grading and staging of prostate cancer.
Braunhut BL; Punnen S; Kryvenko ON
Surg Pathol Clin; 2018 Dec; 11(4):759-774. PubMed ID: 30447840
[TBL] [Abstract] [Full Text] [Related]
14. Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.
Egevad L; Delahunt B; Kristiansen G; Samaratunga H; Varma M
Pathology; 2018 Jan; 50(1):60-73. PubMed ID: 29199015
[TBL] [Abstract] [Full Text] [Related]
15. Unfavorable Intermediate-Risk prostate cancer and the Odds of Upgrading to Gleason 8 or Higher at prostatectomy.
Martin NE; Chen MH; Zhang D; Richie JP; D'Amico AV
Clin Genitourin Cancer; 2017 Apr; 15(2):237-241. PubMed ID: 27426058
[TBL] [Abstract] [Full Text] [Related]
16. A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Falk RT; Staff AC; Bradwin G; Karumanchi SA; Troisi R
Cancer Causes Control; 2016 Aug; 27(8):1009-17. PubMed ID: 27357932
[TBL] [Abstract] [Full Text] [Related]
17. [Patients with prostate cancer after radical prostatectomy: Stage migration and changes in tumor characteristics from 1998-2012].
Walther A; Kron M; Klorek T; Gschwend JE; Herkommer K
Urologe A; 2016 Feb; 55(2):167-75. PubMed ID: 26471796
[TBL] [Abstract] [Full Text] [Related]
18. Primary venous and malignancy, is there any relationship?
Cotto Santana L; Caceres Perkins W
Bol Asoc Med P R; 2015; 107(1):16-9. PubMed ID: 26035979
[TBL] [Abstract] [Full Text] [Related]
19. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.
Rose JN; Crook JM; Pickles T; Keyes M; Morris WJ
Brachytherapy; 2015; 14(3):342-9. PubMed ID: 25727178
[TBL] [Abstract] [Full Text] [Related]
20. Synchronous rectal and prostate cancer--the impact of MRI on incidence and imaging findings.
Sturludóttir M; Martling A; Carlsson S; Blomqvist L
Eur J Radiol; 2015 Apr; 84(4):563-7. PubMed ID: 25638578
[TBL] [Abstract] [Full Text] [Related]
[Next]
